We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

250 hedge funds and large institutions have $465M invested in Editas Medicine in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 64 increasing their positions, 68 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $10.8M

8.38% more ownership

Funds ownership: 70.22% → 78.6% (+8.4%)

6% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 68

5% less funds holding

Funds holding: 264 → 250 (-14)

21% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 53

21% less capital invested

Capital invested by funds: $591M → $465M (-$126M)

Holders
250
Holders Change
-14
Holders Change %
-5.3%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
64
Reduced
68
Closed
53
Calls
$15.7M
Puts
$10.8M
Net Calls
+$4.89M
Net Calls Change
-$232K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$31.5M
2
WP
Woodline Partners
California
+$22.8M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$10.9M
4
Bank of America
Bank of America
North Carolina
+$4.42M
5
BlackRock
BlackRock
New York
+$3.91M

Top Sellers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
-$4.61M
2
NAMA
Nikko Asset Management Americas
New York
-$4.36M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$4.36M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.06M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
176
US Bancorp
Minnesota
$10.1K -$13.2K -1,199 -51%
CT
177
Cambridge Trust
Massachusetts
$9K – – –
CTC
178
Central Trust Company
Missouri
$8.87K +$7.68K +700 +233%
SPIA
179
Steward Partners Investment Advisory
New York
$8.38K +$878 +80 +9%
AF
180
Affiance Financial
Minnesota
$7.1K +$8.78K +800 New
NA
181
NewEdge Advisors
Louisiana
$6.96K +$30.1K +2,742 New
FDCDDQ
182
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.21K – – –
CUAMC
183
China Universal Asset Management Company
China
$6.19K +$593 +54 +8%
TIM
184
Tortoise Investment Management
New York
$6.08K – – –
SFG
185
Steward Financial Group
Texas
$6K +$8.56K +780 New
CFGS
186
Concourse Financial Group Securities
Alabama
$5.68K – – –
HCM
187
Hollencrest Capital Management
California
$5.46K +$6.75K +615 New
FFA
188
Fairfield Financial Advisors
Massachusetts
$4.83K – – –
TPCW
189
TD Private Client Wealth
New York
$4.77K – – –
AWM
190
Ameliora Wealth Management
Switzerland
$4.43K – – –
HI
191
Harbour Investments
Wisconsin
$4.33K +$285 +26 +6%
AAMA
192
Advanced Asset Management Advisors
Ohio
$4.25K +$5.26K +479 New
AA
193
Ancora Advisors
Ohio
$4K – – –
EWM
194
Endurance Wealth Management
Rhode Island
$4K – – –
PVH
195
Psagot Value Holdings
Israel
$4K – – –
First Manhattan
196
First Manhattan
New York
$3.93K – – –
WT
197
Washington Trust
Rhode Island
$3.92K – – –
MWM
198
Mascoma Wealth Management
New Hampshire
$3.81K – – –
GWM
199
Geneos Wealth Management
Colorado
$3.55K – – –
Carson Wealth (CWM LLC)
200
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
6 7
8
9 10

EDIT Hedge Fund Activity: Q4 2022 in Review

250 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2022, worth a combined $465M — down 21% from $591M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EDIT and 42 opened new positions — a net loss of 11 holders — while 68 trimmed existing stakes and 64 added.

The largest buyer was State Street, adding an estimated $31.5M. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $4.61M sold.

  • 250 institutional investors held Editas Medicine (EDIT) as of Q4 2022, down from 264 in Q3 2022.
  • Funds reported $465M of Editas Medicine stock for Q4 2022, down 21% quarter-over-quarter.
  • 42 funds opened new Editas Medicine positions in Q4 2022 and 53 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q4 2022 was State Street, an estimated $31.5M added.
  • The largest Editas Medicine seller in Q4 2022 was Cubist Systematic Strategies, an estimated $4.61M sold.

Based on aggregated 13F filings for Q4 2022.